Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk

Silvia Mangiacavalli1, Paolo Milani2,3, Claudio Salvatore Cartia1

  • 1Division of Hematology, Fondazione IRCCS Policlinico san Matteo, Pavia, Italy.

PubMed

Related Concept Videos